LoreclezoleAlternative Names: R 72063
Latest Information Update: 05 Feb 1998
$50 / €47 *
At a glance
- Originator Janssen L.P.
- Class Antiepileptic drugs; Neuroprotectants; Small molecules; Triazoles
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Epilepsy
Most Recent Events
- 19 Dec 1996 New profile
- 19 Dec 1996 Discontinued-II for Epilepsy in Belgium (PO)
- 19 Dec 1996 Discontinued-II for Epilepsy in France (PO)